Prelabor screening at term using the cerebroplacental ratio and placental growth factor: a pragmatic randomized open-label phase 2 trial.

Sherrell, Helen C; Clifton, Vicki L; Kumar, Sailesh

Sherrell, Helen C; Clifton, Vicki L; Kumar, Sailesh.

Affiliation

Sherrell HC; Mater Research Institute - University of Queensland, Brisbane, Queensland, Australia.
Clifton VL; Mater Research Institute - University of Queensland, Brisbane, Queensland, Australia.
Kumar S; Mater Research Institute - University of Queensland, Brisbane, Queensland, Australia; Mater Mothers' Hospital, Brisbane, Queensland, Australia; Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia. Electronic address: sailesh.kumar@mater.uq.edu.au.

Am J Obstet Gynecol ; 223(3): 429.e1-429.e9, 2020 09.

Article in En | MEDLINE | ID: mdl-32112730

Subject(s)

Labor, Obstetric; Middle Cerebral Artery/diagnostic imaging; Placenta/blood supply; Ultrasonography, Prenatal; Adolescent; Adult; Female; Humans; Intercellular Signaling Peptides and Proteins/urine; Middle Aged; Middle Cerebral Artery/embryology; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, Third; Young Adult

Key words

cerebroplacental ratio; cesarean delivery; fetal distress; fetus; intrapartum fetal compromise; operative birth; placental growth factor; pregnancy; randomized controlled trial

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Placenta / Labor, Obstetric / Ultrasonography, Prenatal / Middle Cerebral Artery Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Screening_studies Limits: Adolescent / Adult / Female / Humans / Middle aged / Pregnancy Language: En Journal: Am J Obstet Gynecol Year: 2020 Type: Article Affiliation country: Australia

Fulltext

XML

PubMed Links

Search on Google